Jahnke K - Search Results

1

Expression of the chemokine receptors CXCR4, CXCR5, and CCR7 in primary central nervous system lymphoma.

Jahnke K, Coupland SE, Na IK, Loddenkemper C, Keilholz U, Korfel A, Stein H, Thiel E, Scheibenbogen C. Jahnke K, et al. Blood. 2005 Jul 1;106(1):384-5. doi: 10.1182/blood-2005-01-0324. Blood. 2005. PMID: 15967804 Free article. No abstract available.

2

Low-grade primary central nervous system lymphoma in immunocompetent patients.

Jahnke K, Thiel E, Schilling A, Herrlinger U, Weller M, Coupland SE, Krümpelmann U, Stein H, Korfel A. Jahnke K, et al. Br J Haematol. 2005 Mar;128(5):616-24. doi: 10.1111/j.1365-2141.2004.05361.x. Br J Haematol. 2005. PMID: 15725082 Free article.

3

Retrospective study of prognostic factors in non-Hodgkin lymphoma secondarily involving the central nervous system.

Jahnke K, Thiel E, Martus P, Schwartz S, Korfel A. Jahnke K, et al. Ann Hematol. 2006 Jan;85(1):45-50. doi: 10.1007/s00277-005-1096-3. Epub 2005 Aug 13. Ann Hematol. 2006. PMID: 16132909

4

Radiologic morphology of low-grade primary central nervous system lymphoma in immunocompetent patients.

Jahnke K, Schilling A, Heidenreich J, Stein H, Brock M, Thiel E, Korfel A. Jahnke K, et al. AJNR Am J Neuroradiol. 2005 Nov-Dec;26(10):2446-54. AJNR Am J Neuroradiol. 2005. PMID: 16286384 Free PMC article.

5

International study on low-grade primary central nervous system lymphoma.

Jahnke K, Korfel A, O'Neill BP, Blay JY, Abrey LE, Martus P, Poortmans PM, Shenkier TN, Batchelor TT, Neuwelt EA, Raizer JJ, Schiff D, Pels H, Herrlinger U, Stein H, Thiel E. Jahnke K, et al. Ann Neurol. 2006 May;59(5):755-62. doi: 10.1002/ana.20804. Ann Neurol. 2006. PMID: 16586496

6

Treatment options for central nervous system lymphomas in immunocompetent patients.

Jahnke K, Thiel E. Jahnke K, et al. Expert Rev Neurother. 2009 Oct;9(10):1497-509. doi: 10.1586/ern.09.100. Expert Rev Neurother. 2009. PMID: 19831839

7

The diagnostic value of cerebrospinal fluid pleocytosis and protein in the detection of lymphomatous meningitis in primary central nervous system lymphomas.

Fischer L, Jahnke K, Martus P, Weller M, Thiel E, Korfel A. Fischer L, et al. Among authors: jahnke k. Haematologica. 2006 Mar;91(3):429-30. Haematologica. 2006. PMID: 16531273

8

Relapse of primary central nervous system lymphoma: clinical features, outcome and prognostic factors.

Jahnke K, Thiel E, Martus P, Herrlinger U, Weller M, Fischer L, Korfel A; German Primary Central Nervous System Lymphoma Study Group. Jahnke K, et al. J Neurooncol. 2006 Nov;80(2):159-65. doi: 10.1007/s11060-006-9165-6. Epub 2006 May 13. J Neurooncol. 2006. PMID: 16699873

9

Systemic high-dose methotrexate plus ifosfamide is highly effective for central nervous system (CNS) involvement of lymphoma.

Fischer L, Korfel A, Kiewe P, Neumann M, Jahnke K, Thiel E. Fischer L, et al. Among authors: jahnke k. Ann Hematol. 2009 Feb;88(2):133-9. doi: 10.1007/s00277-008-0575-8. Epub 2008 Aug 5. Ann Hematol. 2009. PMID: 18679681

10

High-dose methotrexate toxicity in elderly patients with primary central nervous system lymphoma.

Jahnke K, Korfel A, Martus P, Weller M, Herrlinger U, Schmittel A, Fischer L, Thiel E; German Primary Central Nervous System Lymphoma Study Group (G-PCNSL-SG). Jahnke K, et al. Ann Oncol. 2005 Mar;16(3):445-9. doi: 10.1093/annonc/mdi075. Epub 2005 Jan 14. Ann Oncol. 2005. PMID: 15653703 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

377 results

Search Page

Filters